These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 5577487

  • 21. The clinical use of levodopa in the treatment of Parkinson's disease.
    McDowell FH, Markham CH, Lee JE, Treciokas LJ, Ansel RD.
    Contemp Neurol Ser; 1971; 8():175-201. PubMed ID: 4950056
    [No Abstract] [Full Text] [Related]

  • 22. [Therapy of Parkinson's syndrome with L-dopa per os combined with a decarboxylase inhibitor (Ro 46.02)].
    Tissot R, Gaillard JM, Guggisberg M, Gauthier G, De Ajuriaguerra J.
    Neurol Neurocir Psiquiatr; 1969; 10(1):1-25. PubMed ID: 5406970
    [No Abstract] [Full Text] [Related]

  • 23. The clinical pharmacology of levodopa.
    Morgan JP, Bianchine JR.
    Ration Drug Ther; 1971 Jan; 5(1):1-8. PubMed ID: 5162935
    [No Abstract] [Full Text] [Related]

  • 24. [Treatment of Parkinson's syndrome with L-dopa and its methylated derivatives: 3-OMD and 4-OMD associated with a decarboxylase inhibitor. Clinical and biochemical study].
    Tissot R, Bartholini G, Constantinidis J, Eisenring JJ, Geissbühler F, Yanniotis G, de Ajuriaguerra J.
    Schweiz Med Wochenschr; 1973 Oct 20; 103(42):1466-74. PubMed ID: 4750149
    [No Abstract] [Full Text] [Related]

  • 25. Levodopa and physical therapy in treatment of patients with Parkinson's disease.
    Stern PH, McDowell F, Miller JM, Robinson M.
    Arch Phys Med Rehabil; 1970 May 20; 51(5):273-7. PubMed ID: 5420013
    [No Abstract] [Full Text] [Related]

  • 26. L-dopa in Parkinson's disease. A report on 95 cases and review of the literature.
    Lewis I.
    J Med Assoc State Ala; 1971 May 20; 40(11):709-18. PubMed ID: 5573008
    [No Abstract] [Full Text] [Related]

  • 27. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.
    Muenter MD.
    Neurology; 1970 Dec 20; 20(12):6-13. PubMed ID: 4924343
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Treatment of Parkinson's disease with L-dopa alone or combined with Ro 4-4602].
    Barbeau A, Gillo-Joffroy L, Mars H, Arsenault A.
    Rev Can Biol; 1972 Dec 20; 31():Suppl:169-74. PubMed ID: 5052323
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Treatment of Parkinson's disease with L-dopa].
    Guglielmi L, Vecchi L.
    Clin Ter; 1970 May 15; 53(3):259-69. PubMed ID: 4917328
    [No Abstract] [Full Text] [Related]

  • 32. [L-Dopa in the treatment of Parkinson's disease].
    Warot P.
    Lille Med; 1971 May 15; 17():Suppl:329-34. PubMed ID: 5153001
    [No Abstract] [Full Text] [Related]

  • 33. Treatment of Parkinsonism with a combination of levodopa and the decarboxylase inhibitor and RO 46-4602 (a comparison with levodopa treatment alone).
    Dupont E, Hansen E, Melsens S, Parkenberg H, Holm P.
    Acta Neurol Scand Suppl; 1972 May 15; 51():115-7. PubMed ID: 4514334
    [No Abstract] [Full Text] [Related]

  • 34. Plasma concentration of levodopa in patients with Parkinson's disease.
    Rinne UK, Sonninen V, Siirtola T.
    Eur Neurol; 1973 May 15; 10(5):301-10. PubMed ID: 4789106
    [No Abstract] [Full Text] [Related]

  • 35. L-dopa therapy in Parkinson's disease.
    Lipman IJ.
    Va Med Mon (1918); 1971 May 15; 98(5):242-8. PubMed ID: 4931138
    [No Abstract] [Full Text] [Related]

  • 36. [Combination of amantadine and levodopa in the treatment of Parkinson's disease. Indications. Results. Study of 58 cases].
    Sigwald J, Raymondeaud C.
    Nouv Presse Med; 1972 Apr 29; 1(18):1237-9. PubMed ID: 5025538
    [No Abstract] [Full Text] [Related]

  • 37. [Dopa metabolism in relation to the therapy of Parkinson's syndrome].
    Pletscher A, Bartholini G.
    Actual Pharmacol (Paris); 1971 Apr 29; 24():27-49. PubMed ID: 5150621
    [No Abstract] [Full Text] [Related]

  • 38. Dopa-decarboxylase inhibitors.
    Lancet; 1973 May 05; 1(7810):979-80. PubMed ID: 4121597
    [No Abstract] [Full Text] [Related]

  • 39. The present status of levodopa and future approaches to therapy.
    Mones RJ.
    Mt Sinai J Med; 1972 May 05; 39(3):279-86. PubMed ID: 4537267
    [No Abstract] [Full Text] [Related]

  • 40. [Drug therapy of Parkinson's disease with amantadine and levodopa].
    Fieschi C, Nardini M, Casacchia M, Reitano M, Tedone ME, Ferrari P, Robotti E.
    Sist Nerv; 1970 May 05; 22(2):126-43. PubMed ID: 5504552
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.